Eli Lilly lymphoma drug fails in late-stage trial
(Reuters) - Eli Lilly and Co said it will end development of an experimental cancer drug after it failed in a late-stage trial to de...
Read More »(Reuters) - Eli Lilly and Co said it will end development of an experimental cancer drug after it failed in a late-stage trial to de...
Read More »(Reuters) - Pfizer Inc said it could not decide whether to pursue regulatory approval for Pain Therapeutics Inc's painkiller Remoxy,...
Read More »
ZURICH (Reuters) - Novartis said on Friday the U.S. Food and Drug Administration (FDA) had approved its drug Ilaris to treat a serio...
Read More »
By Caroline Humer (Reuters) - Kentucky Democratic Governor Steve Beshear said on Thursday he will expand Medicaid coverage under Pre...
Read More »LILLE/DUBAI (Reuters) - A nurse in a hospital that held France's only confirmed case of the SARS-like coronavirus that has killed 18...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - The number of some cancers related to the human papillomavirus (HPV) increased throu...
Read More »NEW YORK (Reuters) - Anyone wanting to live longer and cut their risk of suffering from heart disease might want to consider getting...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - A group representing U.S. pediatricians said this week that its members should pay s...
Read More »By Kerry Grens NEW YORK (Reuters Health) - Herbal supplements aimed at improving men's sexual abilities often contain the active ing...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Taking additional antioxidant supplements on top of vitamin C, vitamin E and beta car...
Read More »